tiprankstipranks
Advertisement
Advertisement

AU:SNT Stock Latest News

D&A Holdings diluted in Syntara fundraise but commits to second tranche
Company AnnouncementsD&A Holdings diluted in Syntara fundraise but commits to second tranche
12d ago
Syntara completes first tranche of $8m capital raising
PremiumCompany Announcements
Syntara completes first tranche of $8m capital raising
17d ago
Syntara Seeks ASX Quotation for 242.6 Million New Shares
PremiumCompany Announcements
Syntara Seeks ASX Quotation for 242.6 Million New Shares
17d ago
Syntara secures positive FDA review and 52-week data boost for amsulostat
PremiumCompany Announcements
Syntara secures positive FDA review and 52-week data boost for amsulostat
23d ago
Syntara bolsters cash and clinical momentum as key trials advance
PremiumCompany Announcements
Syntara bolsters cash and clinical momentum as key trials advance
23d ago
Syntara to Brief Investors on FDA Feedback and Capital Raising in Upcoming Webinar
PremiumCompany AnnouncementsSyntara to Brief Investors on FDA Feedback and Capital Raising in Upcoming Webinar
24d ago
Syntara Plans Major Share Placement to Raise New Capital
Premium
Company Announcements
Syntara Plans Major Share Placement to Raise New Capital
24d ago
Syntara Outlines Equity Raising Amid Heightened Risk Disclosures
Premium
Company Announcements
Syntara Outlines Equity Raising Amid Heightened Risk Disclosures
24d ago
Syntara raises up to A$10m to fund amsulostat trials and extend cash runway
PremiumCompany Announcements
Syntara raises up to A$10m to fund amsulostat trials and extend cash runway
24d ago
Syntara Wins FDA Backing for Pivotal Amsulostat Trial in Myelofibrosis
PremiumCompany Announcements
Syntara Wins FDA Backing for Pivotal Amsulostat Trial in Myelofibrosis
25d ago
Syntara Halts ASX Trading Ahead of FDA Guidance on Lead Drug Amsulostat
PremiumCompany Announcements
Syntara Halts ASX Trading Ahead of FDA Guidance on Lead Drug Amsulostat
27d ago
Syntara Applies for ASX Quotation of 285,975 New Ordinary Shares
PremiumCompany Announcements
Syntara Applies for ASX Quotation of 285,975 New Ordinary Shares
1M ago
Syntara Issues Over 1.15 Million Unquoted Performance Rights Under Incentive Plan
PremiumCompany AnnouncementsSyntara Issues Over 1.15 Million Unquoted Performance Rights Under Incentive Plan
2M ago
Syntara Flags Risks and Uncertainty Around Future Plans
Premium
Company Announcements
Syntara Flags Risks and Uncertainty Around Future Plans
2M ago
Syntara to Spotlight Expanding Drug Pipeline at NWR Virtual Healthcare Conference
Premium
Company Announcements
Syntara to Spotlight Expanding Drug Pipeline at NWR Virtual Healthcare Conference
2M ago
Syntara secures Parkinson’s UK milestone as Phase 2 iRBD trial fully dosed
PremiumCompany Announcements
Syntara secures Parkinson’s UK milestone as Phase 2 iRBD trial fully dosed
2M ago
Syntara Clears 614,369 Lapsed Performance Rights From Capital Structure
PremiumCompany Announcements
Syntara Clears 614,369 Lapsed Performance Rights From Capital Structure
2M ago
Syntara Seeks ASX Quotation for 609,670 Newly Issued Shares
PremiumCompany Announcements
Syntara Seeks ASX Quotation for 609,670 Newly Issued Shares
3M ago
Syntara Posts Deeper Half-Year Loss as Revenue Slides and Asset Backing Thins
PremiumCompany Announcements
Syntara Posts Deeper Half-Year Loss as Revenue Slides and Asset Backing Thins
3M ago
Syntara Seeks ASX Quotation for 445,750 New Ordinary Shares
PremiumCompany AnnouncementsSyntara Seeks ASX Quotation for 445,750 New Ordinary Shares
3M ago
Syntara Highlights Risks and Uncertainty Around Forward-Looking Statements
Premium
Company Announcements
Syntara Highlights Risks and Uncertainty Around Forward-Looking Statements
4M ago
Syntara Cautions Investors on Risks in Forward-Looking Statements
Premium
Company Announcements
Syntara Cautions Investors on Risks in Forward-Looking Statements
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >